Indium DTPA and Insulin Glargine (U-100) Cartridge Systems and Pens
Determining the interaction of Indium DTPA and Insulin Glargine (U-100) Cartridge Systems and Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111, In-111 DTPA
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium DTPA-Insulin Glargine (U-100) Vials
- Indium DTPA-Insulin Glargine (U-300) Pens
- Indium DTPA-Insulin glargine and lixisenatide
- Indium DTPA-Insulin glargine and lixisenatide Subcutaneous
- Indium DTPA-Insulin glargine, recombinant Subcutaneous
- Indium DTPA-Insulin glulisine
- Insulin Glargine (U-100) Cartridge Systems and Pens-Indium In-111 Pentetreotide
- Insulin Glargine (U-100) Cartridge Systems and Pens-Indium Oxyquinoline
- Insulin Glargine (U-100) Cartridge Systems and Pens-Indocid
- Insulin Glargine (U-100) Cartridge Systems and Pens-Indocin
- Insulin Glargine (U-100) Cartridge Systems and Pens-Indocin (Indomethacin Suppositories)
- Insulin Glargine (U-100) Cartridge Systems and Pens-Indocin (Indomethacin Suspension)